FDA Inspection 1220213 — Patricia Seabra MD
The FDA completed an inspection of Patricia Seabra MD on Sep 22, 2023 in Porto. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 22, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Porto (Portugal)
Additional details
Clinical Investigator (CI)